The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?

ABSTRACT:

Background

The incidence of the highly morbid and potentially lethal gangrenous cholecystitis was reportedly increased during the COVID-19 pandemic. The aim of the ChoCO-W study was to compare the clinical findings and outcomes of acute cholecystitis in patients who had COVID-19 disease with those who did not.

Methods

Data were prospectively collected over 6 months (October 1, 2020, to April 30, 2021) with 1-month follow-up. In October 2020, Delta variant of SARS CoV-2 was isolated for the first time. Demographic and clinical data were analyzed and reported according to the STROBE guidelines. Baseline characteristics and clinical outcomes of patients who had COVID-19 were compared with those who did not.

Results

A total of 2893 patients, from 42 countries, 218 centers

SUBMITTER: De Simone B 

PROVIDER: S-EPMC9755784 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature